|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhibition of brain interleukin-1 attenuates sleep rebound after sleep deprivation in rabbits显示文摘 | Fang JD Levente | 1997 | Am J Physiol1997，273，： | 1 |
| 2 | BRIDGE:an open-label phase Ⅱ trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced,previously untreated,squamous non-small cell lung cancer显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 3 | BRIDGE: an open-label phase II trim evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 4 | Risk factors for bronchopulmonary dysplasia in neonates born at ≤ 1500g(1999-2009)显示文摘 | Zhang HS Fang JD Su HB | | 0，，06： | 1 |
| 5 | Two-dimensional infra- red spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase显示文摘 | FANG C BAUMAN JD DAS K | 2008 | Proc Natl Acad Sci USA2008，105，5： | 1 |
| 6 | Risk factors for bronchopulmonary dysplasia in neonates born at≤1 500 g(1999-2009)显示文摘 | Zhang HS Fang JD Su HB | 2011 | Pediatr Int2011，53，6： | 1 |
| 7 | BRIDGE: an open-label phase II trial evaluating the safety of bevaci- zumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer 显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 8 | BRIDGE:an open label phase II trial evaluating the safety of bevacizumab+carboplatin/paclitaxel as first-line treatment for patients with advanced,previously untreated,squamous non-small cell lung cancer显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 9 | Inhibition of brain interleukin-1 attenuats sleep rebound after sleep deprivation in rabbits显示文摘 | Takahashi Fang JD Levente | 1997 | Am J Physiol1997，273，2： | 1 |
| 10 | BRIDGE:an open-label phase II trial evaluating the safety of bevacizumab+ carboplatin/paclitaxel as first-line treatment for patients with advanced,previously untreated,squamous non-small cell lung cancer显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 11 | BRIDGE: an open-label phase II trial evaluating the safety of bevaci- zumab + carboplatin/paclitaxel as first-line treatment for patients with advanced previously untreated, squamous non-small cell lung cancer 显示文摘 | Hainsworth JD Fang L Huang JE | 2011 | J Thorac Oncol2011，6，1： | 1 |
| 12 | Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation显示文摘 | Fang JD Chou HC Tung HH | 2011 | J Biol Chem2011，286，7： | 1 |
| 13 | Identification of rice black-streaked dwarf Fijivirus in maize with rough dwarf disease in China显示文摘 | Fang SG Yu JL Feng JD | 2001 | Arch Viro2001，146，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员